CellWell record HH-610287
Efficacy of Recombinant Human Parathyroid Hormone 1-34 and Vitamin K2 Combination Therapy in Postmenopausal Osteoporosis
Zhang Z; Xia K; Gong W; Mai R; Liu P; Lu Z
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme ยท 2025
In plain language
In 77 women with postmenopausal osteoporosis randomized to vitamin K2 alone or with rhPTH(1-34), the combination improved bone mineral density and bone metabolism markers more, without more adverse reactions.
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-610287
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.